Creation of rabbit bone and soft tissue tumor using cultured VX2 cells

John A. Handal, Jacob F. Schulz, Gerson B. Florez, Simon C M Kwok, Jasvir S. Khurana, Solomon P. Samuel

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: To create rabbit VX2 bone tumors, it is surgically less demanding to implant VX2 cell suspensions than minced tumor fragments. A VX2 cell line that can be expanded using standard cell culture techniques might provide an unlimited supply of cells needed to create these bone tumors. Therefore, the aim of the present study was to establish a VX2 cell line and verify its tumorigenicity in an athymic mouse and rabbit animal model. Materials and methods: Minced VX2 tumor fragments were allowed to grow as a monolayer in 10 mL Dulbecco's modified Eagle medium/nutrient mixture F-12 (1:1) supplemented with 10% fetal calf serum and passaged multiple times. The tumorigenecity of the cultured VX2 cells were tested in athymic mice (intradermal tumor development) and in New Zealand white rabbits (bone and soft tissue tumor model). Results: The VX2 cells proliferated rapidly in tissue culture flasks containing Dulbecco's modified Eagle medium/nutrient mixture F-12 medium supplemented with 10% fetal bovine serum. After reaching confluence, the VX2 cells can only be subcultured when plated at a greater density (e.g., at a dilution of 1:1). All 6 athymic mice developed tumors within 15 d of VX2 cell suspension implantation. In the rabbits, the VX2 cells were able to produce tumors in muscle tissue and in the distal femurs but not in the proximal tibia. Conclusions: VX2 cell lines can be successfully created from VX2 tumor fragments and passaged multiple times. In contrast to previous reports, the VX2 cells grown in vitro are capable of maintaining their tumorigenecity. However, successful tumor growth might depend on the initial number of cells implanted and the use of extracellular matrices for tumor proliferation.

Original languageEnglish (US)
JournalJournal of Surgical Research
Volume179
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Cultured Cells
Rabbits
Bone and Bones
Neoplasms
Nude Mice
Eagles
Cell Line
Suspensions
Food
Serum
Tibia
Femur
Extracellular Matrix
Animal Models
Cell Culture Techniques
Cell Count
Muscles
Growth

Keywords

  • Bone tumor
  • Cell line
  • Rabbit
  • VX2

ASJC Scopus subject areas

  • Surgery

Cite this

Creation of rabbit bone and soft tissue tumor using cultured VX2 cells. / Handal, John A.; Schulz, Jacob F.; Florez, Gerson B.; Kwok, Simon C M; Khurana, Jasvir S.; Samuel, Solomon P.

In: Journal of Surgical Research, Vol. 179, No. 1, 01.2013.

Research output: Contribution to journalArticle

Handal, John A. ; Schulz, Jacob F. ; Florez, Gerson B. ; Kwok, Simon C M ; Khurana, Jasvir S. ; Samuel, Solomon P. / Creation of rabbit bone and soft tissue tumor using cultured VX2 cells. In: Journal of Surgical Research. 2013 ; Vol. 179, No. 1.
@article{e6188d17e51441b5a839bca2027d6723,
title = "Creation of rabbit bone and soft tissue tumor using cultured VX2 cells",
abstract = "Background: To create rabbit VX2 bone tumors, it is surgically less demanding to implant VX2 cell suspensions than minced tumor fragments. A VX2 cell line that can be expanded using standard cell culture techniques might provide an unlimited supply of cells needed to create these bone tumors. Therefore, the aim of the present study was to establish a VX2 cell line and verify its tumorigenicity in an athymic mouse and rabbit animal model. Materials and methods: Minced VX2 tumor fragments were allowed to grow as a monolayer in 10 mL Dulbecco's modified Eagle medium/nutrient mixture F-12 (1:1) supplemented with 10{\%} fetal calf serum and passaged multiple times. The tumorigenecity of the cultured VX2 cells were tested in athymic mice (intradermal tumor development) and in New Zealand white rabbits (bone and soft tissue tumor model). Results: The VX2 cells proliferated rapidly in tissue culture flasks containing Dulbecco's modified Eagle medium/nutrient mixture F-12 medium supplemented with 10{\%} fetal bovine serum. After reaching confluence, the VX2 cells can only be subcultured when plated at a greater density (e.g., at a dilution of 1:1). All 6 athymic mice developed tumors within 15 d of VX2 cell suspension implantation. In the rabbits, the VX2 cells were able to produce tumors in muscle tissue and in the distal femurs but not in the proximal tibia. Conclusions: VX2 cell lines can be successfully created from VX2 tumor fragments and passaged multiple times. In contrast to previous reports, the VX2 cells grown in vitro are capable of maintaining their tumorigenecity. However, successful tumor growth might depend on the initial number of cells implanted and the use of extracellular matrices for tumor proliferation.",
keywords = "Bone tumor, Cell line, Rabbit, VX2",
author = "Handal, {John A.} and Schulz, {Jacob F.} and Florez, {Gerson B.} and Kwok, {Simon C M} and Khurana, {Jasvir S.} and Samuel, {Solomon P.}",
year = "2013",
month = "1",
doi = "10.1016/j.jss.2012.02.061",
language = "English (US)",
volume = "179",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Creation of rabbit bone and soft tissue tumor using cultured VX2 cells

AU - Handal, John A.

AU - Schulz, Jacob F.

AU - Florez, Gerson B.

AU - Kwok, Simon C M

AU - Khurana, Jasvir S.

AU - Samuel, Solomon P.

PY - 2013/1

Y1 - 2013/1

N2 - Background: To create rabbit VX2 bone tumors, it is surgically less demanding to implant VX2 cell suspensions than minced tumor fragments. A VX2 cell line that can be expanded using standard cell culture techniques might provide an unlimited supply of cells needed to create these bone tumors. Therefore, the aim of the present study was to establish a VX2 cell line and verify its tumorigenicity in an athymic mouse and rabbit animal model. Materials and methods: Minced VX2 tumor fragments were allowed to grow as a monolayer in 10 mL Dulbecco's modified Eagle medium/nutrient mixture F-12 (1:1) supplemented with 10% fetal calf serum and passaged multiple times. The tumorigenecity of the cultured VX2 cells were tested in athymic mice (intradermal tumor development) and in New Zealand white rabbits (bone and soft tissue tumor model). Results: The VX2 cells proliferated rapidly in tissue culture flasks containing Dulbecco's modified Eagle medium/nutrient mixture F-12 medium supplemented with 10% fetal bovine serum. After reaching confluence, the VX2 cells can only be subcultured when plated at a greater density (e.g., at a dilution of 1:1). All 6 athymic mice developed tumors within 15 d of VX2 cell suspension implantation. In the rabbits, the VX2 cells were able to produce tumors in muscle tissue and in the distal femurs but not in the proximal tibia. Conclusions: VX2 cell lines can be successfully created from VX2 tumor fragments and passaged multiple times. In contrast to previous reports, the VX2 cells grown in vitro are capable of maintaining their tumorigenecity. However, successful tumor growth might depend on the initial number of cells implanted and the use of extracellular matrices for tumor proliferation.

AB - Background: To create rabbit VX2 bone tumors, it is surgically less demanding to implant VX2 cell suspensions than minced tumor fragments. A VX2 cell line that can be expanded using standard cell culture techniques might provide an unlimited supply of cells needed to create these bone tumors. Therefore, the aim of the present study was to establish a VX2 cell line and verify its tumorigenicity in an athymic mouse and rabbit animal model. Materials and methods: Minced VX2 tumor fragments were allowed to grow as a monolayer in 10 mL Dulbecco's modified Eagle medium/nutrient mixture F-12 (1:1) supplemented with 10% fetal calf serum and passaged multiple times. The tumorigenecity of the cultured VX2 cells were tested in athymic mice (intradermal tumor development) and in New Zealand white rabbits (bone and soft tissue tumor model). Results: The VX2 cells proliferated rapidly in tissue culture flasks containing Dulbecco's modified Eagle medium/nutrient mixture F-12 medium supplemented with 10% fetal bovine serum. After reaching confluence, the VX2 cells can only be subcultured when plated at a greater density (e.g., at a dilution of 1:1). All 6 athymic mice developed tumors within 15 d of VX2 cell suspension implantation. In the rabbits, the VX2 cells were able to produce tumors in muscle tissue and in the distal femurs but not in the proximal tibia. Conclusions: VX2 cell lines can be successfully created from VX2 tumor fragments and passaged multiple times. In contrast to previous reports, the VX2 cells grown in vitro are capable of maintaining their tumorigenecity. However, successful tumor growth might depend on the initial number of cells implanted and the use of extracellular matrices for tumor proliferation.

KW - Bone tumor

KW - Cell line

KW - Rabbit

KW - VX2

UR - http://www.scopus.com/inward/record.url?scp=84870674541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870674541&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2012.02.061

DO - 10.1016/j.jss.2012.02.061

M3 - Article

C2 - 22475353

AN - SCOPUS:84870674541

VL - 179

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -